Get the latest Science News and Discoveries

Oncotarget: CABYR-a/b and CABYR-c hold promise as targets for specific immunotherapy


None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of Immunotherapy

Immunotherapy

Related news:

News photo

New immunotherapy 'highly effective' against hepatitis B

News photo

New immunotherapy 'highly effective' against hepatitis B

News photo

New Immunotherapy “Highly Effective” Against Hepatitis B Virus